Histopathology of fathead minnow (Pimephales promelas) exposed to hydroxylated fullerenes

Nanotoxicology

Volumn 8, Issue 7, 2014, Pages 755-763

  Jovanović, Boris ^a   Whitley, Elizabeth M ^b   Palić, Dušan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Fish; Hydroxylated fullerenes; Kidney; Liver; Nanoparticles; Pathology

Indexed keywords

FULLERENE DERIVATIVE; GLYCOGEN; HYDROXYLATED FULLERENE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; FULLERENE C60;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CYTOPLASM; EXPOSURE; FEMALE; GILL; HEMATOPOIESIS; HEMATOPOIETIC CELL; HISTOPATHOLOGY; KIDNEY; KIDNEY INTERSTITIUM; LEUKOCYTE; LEUKOCYTE COUNT; LIVER; LIVER CELL; MACROPHAGE; MALE; NONHUMAN; PIMEPHALES PROMELAS; PRIORITY JOURNAL; SKIN; ANIMAL; CHEMISTRY; CYPRINIDAE; DRUG EFFECT; PATHOLOGY; TISSUE DISTRIBUTION;

ANIMALS; CYPRINIDAE; FEMALE; FULLERENES; HEPATOCYTES; KIDNEY; LIVER; MALE; TISSUE DISTRIBUTION;

MLCS; MLOWN;

EID: 84904231468     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.828794     Document Type: Article

References (31)

1. Ankley GT, Villeneuve DL. 2006. The fathead minnow in aquatic toxicology: past, present and future. Aquat Toxicol 78:91-102.
2. Bogdanovic G, Kojic V, Dordevic A, Canadanovic-Brunet J, Vojinovic-Miloradov M, Baltic VV. 2004. Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity. Toxicol In Vitro 18:629-637.
3. Bunz H, Plankenhorn S, Klein R. 2012. Effect of buckminsterfullerenes on cells of the innate and adaptive immune system: an in vitro study with human peripheral blood mononuclear cells. Int Nanomed 7:4571-4580.
4. Cai X, Hao J, Zhang X, Yu B, Ren J, Luo C, et al. 2010. The polyhydroxylated fullerene derivative C60(OH)24 protects mice from ionizing- radiation-induced immune and mitochondrial dysfunction. Toxicol Appl Pharmacol 243:27-34.
5. Cai X, Jia H, Liu Z, Hou B, Luo C, Feng Z, et al. 2008. Polyhydroxylated fullerene derivative C60(OH)24 prevents mitochondrial dysfunction and oxidative damage in an MPP+ induced cellular model of Parkinson?s disease. J Neurosci Res 86:3622-3634.
6. Cataldo F, da Ros T. editors. 2008. Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes. 1st ed. Berlin: Springer. pp 223-266.
7. Chen HH, Yu C, Ueng TH, Chen S, Chen BJ, Huang KJ, et al. 1998. Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicol Pathol 26(1):143-151.
8. Chen Y-W, Hwang KC, Yen C-C, Lai Y-L. 2004. Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. J Physiol Regul Integr Comp Physiol 287:21-26.
9. Dugan LL, Lovett EG, Quick KL, Lotharius J, Lin TT, O?Malley KL. 2001. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord 7:243-246.
10. Gelderman MP, Simakova O, Clogston JD, Patri AK, Siddiqui SF, Vostal AC, et al. 2008. Adverse effects of fullerenes on endothelial cells: Fullerenol C60(OH)24 induced tissue factor and ICAM-1 membrane expression and apoptosis in vitro. Int J Nanomedicine 3(1):59-68.
11. Hinton DE, Segner H, Au DWT, Kullman SW, Hardman RC. 2008. Liver toxicity. In: Di Guilio RT, Hinton DE, editors. The toxicology of fishes. Boca Raton, FL, USA: CRC Press. Taylor and Francis Group. pp 327-400.
12. Johnson-Lyles DN, Peifley K, Lockett S, Neun BW, Hansen M, Clogston J, et al. 2010. Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol 248:249-258.
13. Jovanovic? B, Anastasova L, Rowe EW, Palic? D. 2011. Hydroxylated fullerenes inhibit neutrophil function in fathead minnow (Pimephales promelas Rafinesque, 1820). Aquat Toxicol 101:474-482.
14. Kobayashi I, Sekiya M, Moritomo T, Ototake M, Nakanishi T. 2006. Demonstration of hematopoietic stem cells in ginbuna carp (Carassius auratus langsdorfii) kidney. Dev Comp Immunol 30:1034-1046.
15. Kokubo K. 2012. Water soluble single-nano carbon particles: fullerenol and its derivatives. In: Hashim AA, editor. The delivery of nanoparticles. InTech. pp 317-332.ISBN 978-953-51-0615-9.
16. Lin AM, Fang SF, Lin SZ, Chou CK, Luh TY, Ho LT. 2002. Local carboxyfullerene protects cortical infarction in rat brain. Neurosci Res 43(4):317-321.
17. Markovic Z, Trajkovic V. 2008. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes C60. Biomaterials 29:3561-3573.
18. Monteiro-Riviere NA, Linder KE, Inman AO, Saathoff JG, Xia XR, Riviere JE. 2012. Lack of hydroxylated fullerene toxicity after intravenous administration to female Sprague-Dawley rats. J Toxicol Environ Health A 75(7):367-373.
19. Mori T, Ito S, Kita T, Narita M, Suzuki T, Matsubayashi K, et al. 2007b. Oxidative stress in methamphetamine-induced self-injurious behavior in mice. Behav Pharmacol 18(3):239-249.
20. Mori T, Ito S, Namiki M, Suzuki T, Kobayashi S, Matsubayashi K, et al. 2007a. Involvement of free radicals followed by the activation of phospholipase A2 in the mechanism that underlies the combined effects of methamphetamine and morphine on subacute toxicity or lethality in mice: comparison of the therapeutic potential of fullerene, mepacrine, and cooling. Toxicology 236(3):149-157.
21. Nakagawa Y, Suzuki T, Ishii H, Nakae D, Ogata A. 2011. Cytotoxic effects of hydroxylated fullerenes on isolated rat hepatocytes via mitochondrial dysfunction. Arch Toxicol 85(11):1429-1440.
22. Pirutin SK, Turovetski VB, Kedrov AV, Kudriashov IB, Shaitan KV, Rubin AB. 2012. Effect of hydroxylated fullerene C60(OH)25 on macrophage plasma membrane integrity. Radiats Biol Radioecol 52(3):252-256.
23. Ryan JJ, Bateman HR, Stover A, Gomez G, Norton SK, Zhao W, et al. 2007. Fullerene nanomaterials inhibit the allergic response. J Immunol 179:665-672.
24. Tramer F, Da Ros T, Passamonti S. 2012. Screening of fullerene toxicity by hemolysis assay. Methods Mol Biol 926:203-217.
25. Ueng T-H, Kang J-J, Wang H-W, Cheng Y-W, Chiang LY. 1997. Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. Toxicol Lett 93:29-37.
26. Vapa I, Milic-Torres V, Djordjevic A, Vasovic V, Srdjenovic B, Dragojevic-Simic V, et al. 2012. Effect of fullerenol C60(OH)24 on lipid peroxidation of kidneys, testes and lungs in rats treated with doxorubicine. Eur J Drug Metab Pharmacokinet 37(4):301-307.
27. Wang J, Chen C, Li B, Yu H, Zhao Y, Sun J, et al. 2006. Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice. Biochem Pharmacol 71(6):872-881.
28. Yamada T, Nakaoka R, Sawada R, Matsuoka A, Tsuchiya T. 2010. Effects of intracerebral microinjection of hydroxylated-[60] fullerene on brain monoamine concentrations and locomotor behavior in rats. J Nanosci Nanotechnol 10(1):604-611.
29. Yang D, Zhao Y, Guo H, Li Y, Tewary P, Xing G, et al. 2010. Nanoparticles, [Gd@C82(OH)22]n, induces dendritic cell maturation and activates Th1 immune responses. ACS Nano 4(2):1178-1186.
30. Yin J-J, Lao F, Fu PP, Wamer WG, Zhao Y, Wang PC, et al. 2009. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials 30:611-621.
31. Zapata A. 1979. Ultrastructural study of the teleost fish kidney. Dev Comp Immunol 3:55-65.